Provided by Tiger Fintech (Singapore) Pte. Ltd.

Galmed Pharmaceuticals

1.87
+0.09005.06%
Post-market: 1.870.00000.00%19:58 EDT
Volume:943.59K
Turnover:1.76M
Market Cap:4.22M
PE:-0.31
High:1.90
Open:1.86
Low:1.81
Close:1.78
Loading ...

Galmed Pharmaceuticals Unveils Biomarker Signature for Aramchol, Expanding Market Potential

TIPRANKS
·
27 May

Galmed Pharmaceuticals Ltd - Phase 3 Armor Study Shows Significant Reduction in Inflammation and Cardiac Stress

THOMSON REUTERS
·
27 May

Galmed Pharmaceuticals Ltd - Discovers Proprietary Biomarker Signature for Aramchol

THOMSON REUTERS
·
27 May

Galmed Pharmaceuticals Q1 EPS $(0.62) Beats $(0.89) Estimate

Benzinga
·
22 May

Galmed Pharmaceuticals Reports Q1 2025 Financials: Net Loss Narrows to $1.1M, EPS Improves to $0.62

Reuters
·
22 May

Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS
·
22 May

Galmed Pharmaceuticals Q1 EPS $ -0.62

THOMSON REUTERS
·
22 May

Press Release: Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Dow Jones
·
22 May

Galmed Pharmaceuticals Announces Promising Preclinical Results of Aramchol in Treating PSC-Related Fibrosis, Paving Way for Future Clinical Trials

Reuters
·
13 May

Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Galmed Pharmaceuticals (GLMD) and Xilio Therapeutics (XLO)

TIPRANKS
·
09 May

BRIEF-Galmed Announces First Time Results In Oncology Studies Aramchol Significantly Enhances Bayer's Regorafenib Effect In Gi Cancer Models

Reuters
·
06 May

Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in Gi Cancer Models

THOMSON REUTERS
·
06 May

Galmed Pharmaceuticals Ltd - Phase 1B Study of Aramchol and Regorafenib to Start Q4 2025

THOMSON REUTERS
·
06 May

Biotech Alert: Searches spiking for these stocks today

TipRanks
·
02 May

Analysts Conflicted on These Healthcare Names: Galmed Pharmaceuticals (GLMD) and Regeneron (REGN)

TIPRANKS
·
29 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Marriott, Wells Fargo, Insulet

Reuters
·
28 Apr

Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings

Benzinga
·
28 Apr

BRIEF-Galmed Signed Term Sheet For The Development Of Novel Semaglutide Sublingual Formulation

Reuters
·
28 Apr

Galmed Pharmaceuticals Ltd - New Formulation Offers Non-Invasive Alternative to Injectable Semaglutide

THOMSON REUTERS
·
28 Apr

Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation

PR Newswire
·
28 Apr